Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
43.84
+2.16 (5.18%)
At close: Nov 20, 2025, 4:00 PM EST
44.00
+0.16 (0.36%)
After-hours: Nov 20, 2025, 7:40 PM EST
Rigel Pharmaceuticals Employees
As of December 31, 2024, Rigel Pharmaceuticals had 164 total employees, including 162 full-time and 2 part-time employees. The number of employees increased by 17 or 11.56% compared to the previous year.
Employees
164
Change (1Y)
17
Growth (1Y)
11.56%
Revenue / Employee
$1,719,976
Profits / Employee
$690,854
Market Cap
795.75M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 164 | 17 | 11.56% |
| Dec 31, 2023 | 147 | -8 | -5.16% |
| Dec 31, 2022 | 155 | -10 | -6.06% |
| Dec 31, 2021 | 165 | -4 | -2.37% |
| Dec 31, 2020 | 169 | 6 | 3.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RIGL News
- 3 days ago - Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology - PRNewsWire
- 8 days ago - Rigel to Present at the Jefferies Global Healthcare Conference in London - PRNewsWire
- 16 days ago - Rigel Pharmaceuticals, Inc. (RIGL) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update - PRNewsWire
- 17 days ago - Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition - PRNewsWire
- 21 days ago - This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is 'growing substantially' - CNBC
- 22 days ago - Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update - PRNewsWire
- 6 weeks ago - Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS - PRNewsWire